Evidence map›Paper›PMID 41204030›Full record

ReviewCell and tissue research2025

Obligate intracellular bacteria and host cell death pathways-the matter of life and death.

Manuela Szperlinski, Elias Schermuly, Anja Lührmann, Vera Kozjak-Pavlovic

Abstract readReview
In one paragraph

Review in Cell and tissue research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manuela SzperlinskiMikrobiologisches Institut, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Elias SchermulyMikrobiologisches Institut, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Anja LührmannMikrobiologisches Institut, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. anja.luehrmann@uk-erlangen.de.
Vera Kozjak-PavlovicChair of Microbiology, University of Würzburg, Biocenter, Würzburg, Germany. vera.kozjak@uni-wuerzburg.de.

Funding

Deutsche Forschungsgemeinschaft DFG/ANR project MIMICDeutsche Forschungsgemeinschaft GRK 2581Deutsche Forschungsgemeinschaft LU 1357/5-2
6 · The paper itself

Abstract

To limit the damage caused by pathogenic bacteria, host organisms possess different defense systems and mechanisms for preventing infection, combating the pathogens, and creating a memory that will avert recurrent infections. Pathogens, on the other hand, have developed countermeasures to enable their replication and spreading. For intracellular pathogenic bacteria, the battleground is localized at the cellular level. Different cell types, including phagocytic, epithelial, and endothelial cells, fibroblasts, and trophoblasts, not only are equipped with diverse defense tools, but also provide different microenvironments, such as varying oxygen tension, pH levels, tonicity, and nutrient supply. The outcome of the infection depends on these conditions in conjunction with microbe-derived virulence factors and bacterial microenvironment needs. Here, we will review the current knowledge on how eukaryotic cells fight obligate intracellular bacteria and how these pathogens counteract the host cell defenses, focusing on cell death pathways. Whereas common cellular strategies for dealing with intracellular bacteria exist, there are also unique approaches adjusted to the individual properties of the pathogen.

Indexed as

BacteriaCell DeathHost-Pathogen InteractionsAnimalsHumansAnaplasmaApoptosisCell deathChlamydiaCoxiellaEhrlichiaObligate intracellular bacteriaOrientiaRickettsiaSimkania

Identifiers

PMID41204030
PMCPMC12727909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.